ABEONA THERAPEUTICS INC. (ABEO) Total liabilities 2016–2025
ABEONA THERAPEUTICS INC. (ABEO) total liabilities at each fiscal year-end, per SEC filings.
$60.4MFY2025 · since FY2016: $12.0M → $60.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $60.4M | — |
| FY2023 | $49.2M | +31.3% |
| FY2022 | $37.5M | +0.6% |
| FY2021 | $37.2M | -23.5% |
| FY2020 | $48.6M | — |
| FY2018 | $40.4M | +365.6% |
| FY2017 | $8.7M | -27.5% |
| FY2016 | $12.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABEO financial trends
ABEO RevenueABEO Net incomeABEO Net marginABEO Gross profitABEO Gross marginABEO Operating incomeABEO Operating marginABEO Operating cash flowABEO Free cash flowABEO Capital expendituresABEO Return on equityABEO Stock buybacksABEO Dividends paidABEO Total assetsABEO Shareholders’ equityABEO overview →